Biopharmaceutical School

At PTI's Biopharmaceutical School you will learn a comprehensive and complete overview of the biopharmaceutical industry. The programme will cover the discovery of a large molecule from R&D, pre-clinical, clinical, upstream and downstream processing through to immunogenicity, stability and formulation.

Procedures to obtain regulatory approval to market a biological product will be discussed. The course faculty comprises of recognised experts from the biopharmaceutical industry who will teach you all the strategies you will need to know in order to tackle challenges typical to this particular industry.

• Dr Adrian Haines, Senior Group Leader, Lonza BiologicsDr Adrian Haines, Principal Scientist, Process Development Sciences, Lonza Biologics
• Kit Erlebach, Head of Technical Operations, Fujifilm Diosynth Biotechnologies
• Dr Isabelle Cludts, Biotherapeutics Group, National Institute for Biological Standards and Control, Health Protection Agency
• Dr Michael Weiss, Department of Pharmacology, Martin Luther University
• Roger Holdsworth, Independent Consultant
• Lorna Brazell, Partner, Bird & Bird
• Charles Christy, Associate Director, Biotechnology, Covance
• Dr Jane Robinson, Principle Scientist, Biotherapeutics Group, National Institute for Biological Standards and Control
• Niamh Kinsella, Consultant, NDA Regulatory Science Ltd.
• Richard Dennett, Director, Voisin Consulting Life Sciences
• Sally Shorthose, Partner, Bird & Bird

Follow PTI on twitter:
@PTI_Courses

http://twitter.com/#!/PTI_Courses